Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA PMA

Gases used within eye to place pressure on detached retina

PMA Number: P230012 · 2026-09-30

ApplicantAlcon Research, LLC
Decision Date2026-09-30
PMA NumberP230012
Product CodeLPO
Device ClassClass 3
Medical SpecialtyO
Regulation Number21 CFR 8
Advisory CommitteeOP

Device Summary

Gases used within eye to place pressure on detached retina is the device name listed in this FDA 510(k) record. The listed applicant is Alcon Research, LLC. It received FDA 510(k) clearance on 2026-09-30. The device is classified under product code LPO. It was reviewed by the OP advisory panel.

Frequently Asked Questions

What is the Gases used within eye to place pressure on detached retina?

Gases used within eye to place pressure on detached retina is a medical device that received FDA 510(k) clearance on 2026-09-30. The listed applicant is Alcon Research, LLC.

When did Gases used within eye to place pressure on detached retina receive FDA 510(k) clearance?

The clearance date for Gases used within eye to place pressure on detached retina can be found in the official FDA records.

Who is the listed applicant for Gases used within eye to place pressure on detached retina?

The FDA 510(k) record lists Alcon Research, LLC as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Gases used within eye to place pressure on detached retina?

The FDA product code for Gases used within eye to place pressure on detached retina is LPO.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT04745156A Study Using Brain Stimulation and Behavioral Therapy to Increase Extent of Resection in Low-Grade GliomasNOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDED

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑